Annual Shareholders Equity
$23.19 M
-$30.88 M-57.11%
30 September 2022
Summary:
NeuBase Therapeutics annual stockholders equity is currently $23.19 million, with the most recent change of -$30.88 million (-57.11%) on 30 September 2022. During the last 3 years, it has fallen by -$30.88 million (-57.11%).NBSE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$9.14 M
-$2.11 M-18.76%
30 September 2023
Summary:
NeuBase Therapeutics quarterly stockholders equity is currently $9.14 million, with the most recent change of -$2.11 million (-18.76%) on 30 September 2023.NBSE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -57.1% | -83.1% |
| 5 y5 years | +131.2% | -8.9% |
NBSE Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -57.1% | -84.8% |
NeuBase Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $9.14 M(-18.8%) |
| June 2023 | - | $11.25 M(-22.2%) |
| Mar 2023 | - | $14.45 M(-20.7%) |
| Dec 2022 | - | $18.22 M(-21.4%) |
| Sept 2022 | $23.19 M(-57.1%) | $23.19 M(-23.5%) |
| June 2022 | - | $30.31 M(-20.6%) |
| Mar 2022 | - | $38.16 M(-19.0%) |
| Dec 2021 | - | $47.13 M(-12.8%) |
| Sept 2021 | $54.07 M(+72.8%) | $54.07 M(-10.3%) |
| June 2021 | - | $60.28 M(+151.8%) |
| Mar 2021 | - | $23.94 M(-16.1%) |
| Dec 2020 | - | $28.52 M(-8.9%) |
| Sept 2020 | $31.29 M(+212.0%) | $31.29 M(-9.8%) |
| June 2020 | - | $34.68 M(+769.4%) |
| Mar 2020 | - | $3.99 M(-43.2%) |
| Dec 2019 | - | $7.03 M(-29.9%) |
| Sept 2019 | $10.03 M(<-9900.0%) | $10.03 M(+26.3%) |
| June 2019 | - | $7.94 M(-11.8%) |
| Mar 2019 | - | $9.01 M(-10.6%) |
| Dec 2018 | - | $10.08 M(<-9900.0%) |
| Sept 2018 | -$41.90 K(-100.2%) | -$41.90 K(-100.2%) |
| June 2018 | - | $17.18 M(-2.7%) |
| Mar 2018 | - | $17.66 M(-10.3%) |
| Dec 2017 | - | $19.68 M(-13.8%) |
| Sept 2017 | $22.84 M(-8.5%) | $22.84 M(-18.3%) |
| June 2017 | - | $27.97 M(+50.2%) |
| Mar 2017 | - | $18.62 M(-27.9%) |
| Dec 2016 | - | $25.84 M(+3.5%) |
| Sept 2016 | $24.96 M(-41.3%) | $24.96 M(-14.0%) |
| June 2016 | - | $29.02 M(-18.4%) |
| Mar 2016 | - | $35.58 M(-8.5%) |
| Dec 2015 | - | $38.87 M(-8.5%) |
| Sept 2015 | $42.49 M(+58.8%) | $42.49 M(-6.8%) |
| June 2015 | - | $45.59 M(-5.3%) |
| Mar 2015 | - | $48.16 M(+113.0%) |
| Dec 2014 | - | $22.61 M(-15.5%) |
| Sept 2014 | $26.75 M(+408.2%) | $26.75 M(-7.1%) |
| June 2014 | - | $28.79 M(+765.2%) |
| Mar 2014 | - | $3.33 M(-23.3%) |
| Dec 2013 | - | $4.34 M(-17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | $5.26 M(+117.0%) | $5.26 M(-20.3%) |
| June 2013 | - | $6.61 M(+189.9%) |
| Mar 2013 | - | $2.28 M(+322.0%) |
| Dec 2012 | - | $540.20 K(-77.7%) |
| Sept 2012 | $2.43 M(-150.7%) | $2.43 M(+1270.7%) |
| June 2012 | - | $177.00 K(-125.5%) |
| Mar 2012 | - | -$694.00 K(-79.9%) |
| Dec 2011 | - | -$3.45 M(-27.8%) |
| Sept 2011 | -$4.78 M(+1150.1%) | -$4.78 M(+35.3%) |
| June 2011 | - | -$3.53 M(+716.2%) |
| Mar 2011 | - | -$433.00 K(-41.7%) |
| Dec 2010 | - | -$743.10 K(+94.3%) |
| Sept 2010 | -$382.50 K(-162.4%) | -$382.50 K(-73.4%) |
| June 2010 | - | -$1.44 M(-3.0%) |
| Mar 2010 | - | -$1.48 M(-245.1%) |
| Dec 2009 | - | $1.02 M(+66.7%) |
| Sept 2009 | $612.70 K(+1745.5%) | $612.70 K(-17.2%) |
| June 2009 | - | $740.00 K(-1256.3%) |
| Mar 2009 | - | -$64.00 K(+93.9%) |
| Dec 2008 | - | -$33.00 K(-199.4%) |
| Sept 2008 | $33.20 K(-112.6%) | $33.20 K(-22.8%) |
| June 2008 | - | $43.00 K(+34.4%) |
| Mar 2008 | - | $32.00 K(-74.2%) |
| Dec 2007 | - | $124.00 K(-147.1%) |
| Sept 2007 | -$263.00 K(+3107.3%) | -$263.00 K(+270.4%) |
| June 2007 | - | -$71.00 K(-102.2%) |
| Mar 2007 | - | $3.18 M(<-9900.0%) |
| Dec 2006 | -$8200.00(-100.7%) | -$8200.00(-139.2%) |
| Sept 2006 | - | $20.90 K(-94.8%) |
| June 2006 | - | $402.30 K(-67.1%) |
| Mar 2006 | - | $1.22 M(+3.8%) |
| Dec 2005 | $1.18 M(-2.4%) | $1.18 M(-14.3%) |
| Sept 2005 | - | $1.38 M(+8.9%) |
| June 2005 | - | $1.26 M(-0.5%) |
| Mar 2005 | - | $1.27 M(+5.1%) |
| Dec 2004 | $1.21 M(+30.9%) | $1.21 M(+6.8%) |
| Sept 2004 | - | $1.13 M(+4.6%) |
| June 2004 | - | $1.08 M(+9.4%) |
| Mar 2004 | - | $989.20 K |
| Dec 2003 | $923.80 K | - |
FAQ
- What is NeuBase Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NeuBase Therapeutics?
What is NeuBase Therapeutics annual stockholders equity?
The current annual shareholders equity of NBSE is $23.19 M
What is the all time high annual shareholders equity for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual stockholders equity is $54.07 M
What is NeuBase Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of NBSE is $9.14 M
What is the all time high quarterly shareholders equity for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly stockholders equity is $60.28 M